Drug Trial Radar · NCT04658862
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
518
Actual
Start
Dec 7, 2020
Primary completion
Dec 30, 2026
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Dec 9, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of study is to compare bladder intact-event free survival (BI-EFS) in participants receiving TAR-200 in combination with intravenous (IV) cetrelimab versus concurrent chemoradiotherapy.
Conditions
- Urinary Bladder Neoplasms
Interventions
CetrelimabBiological
Participants will receive intravenous Cetrelimab.
TAR-200Drug
Participants will receive intravesical TAR-200.
CisplatinDrug
Participants will receive cisplatin intravenously.
GemcitabineDrug
Participants will receive gemcitabine intravenously.
Conventional radiation therapyRadiation
Participants will receive conventional radiation therapy for bladder (64 gy).
Hypo-fractioned radiation therapyRadiation
Participants will receive hypo-fractioned radiation therapy for bladder (55 gy).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time from Randomization to the First Bladder Intact Event-free Survival (BI-EFS) eventTime frame: Up to 8 years
Locations
290 sites in 25 countries. Site status is shown where the registry gives one.
Loma Linda Univ Faculty Medic
Loma Linda, California
University of Southern California
Los Angeles, California
Providence Saint John s Health Center
Santa Monica, California
Stanford University Medical Center
Stanford, California
The Urology Center of Colorado
Denver, Colorado
Foothills Urology - Golden Off
Golden, Colorado
Boca Raton Regional Hospital
Boca Raton, Florida
Urological Research Network
Hialeah, Florida
Memorial Healthcare System
Pembroke Pines, Florida
Winship Cancer Institute of Emory University
Atlanta, Georgia
DuPage Medical Group
Lisle, Illinois
University Hospitals Seidman Cancer Center
Ann Arbor, Michigan
Michigan Institute of Urology
Troy, Michigan
Adult Pediatric Urology & Urogynecology, P.C
Omaha, Nebraska
Garden State Urology
Morristown, New Jersey
New Jersey Urology LLC
Voorhees Township, New Jersey
Cardiology Clinic at Montefiore Hutchinson Complex
The Bronx, New York
Duke University Medical Center
Durham, North Carolina
Vidant Urology - Greenville
Greenville, North Carolina
Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center
Winston-Salem, North Carolina
Wexner Medical Center at the Ohio State University
Columbus, Ohio
Stephenson Cancer Center
Oklahoma City, Oklahoma
MidLantic Urology
Bala-Cynwyd, Pennsylvania
Carolina Urologic Research Center
Myrtle Beach, South Carolina
University of Tennessee Medical Center
Knoxville, Tennessee
Houston Metro Urology
Houston, Texas
University of Texas Medical Branch
League City, Texas
Virginia Oncology Associates
Norfolk, Virginia
Fundacion Intecnus
Bariloche, Argentina
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina
Asociacion de Beneficencia Hospital Sirio Libanes
Buenos Aires, Argentina
Instituto Medico Especializado Alexander Fleming
Buenos Aires, Argentina
Centro de Urologia (CDU)
Ciudad Automoma Buenos Aires, Argentina
Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica
Córdoba, Argentina
Centro Urologico Profesor Bengio
Córdoba, Argentina
Sanatorio Allende Cerro
Córdoba, Argentina
Centro Oncologico Riojano Integral (Cori)
La Rioja, Argentina
Centro de Investigacion Pergamino SA
Pergamino, Argentina
CEDIC Centro de Investigaciones Clinicas
Viedma, Argentina
Flinders Medical Centre
Bedford Park, Australia
Showing 40 of 290 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.